Pertuzumab: Development Beyond Breast Cancer | Anticancer Research
References in Evolving novel anti-HER2 strategies - The Lancet Oncology
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes - ScienceDirect
Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silicobased mechanism | Breast Cancer Research | Full Text
Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody - Journal of Biological Chemistry
SciELO - Brasil - Pertuzumab and trastuzumab: the rationale way to synergy Pertuzumab and trastuzumab: the rationale way to synergy
Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer | British Journal of Cancer
Targeting HER family receptors in breast cancer - ppt video online download
Mechanisms and Actions of HER2-Targeting Agents in Breast Cancer (Transcript)
Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer | Journal for ImmunoTherapy of Cancer
Proposed Mechanism of Action | PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx)
Figure 1 from Pertuzumab: Optimizing HER2 Blockade | Semantic Scholar
Pertuzumab Overview - Creative Biolabs
Cancers | Free Full-Text | Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer
Figure 1 | Recent Developments in HER2-Directed Therapy in Breast Cancer | SpringerLink
Pertuzumab - Wikipedia
Anti-HER2 therapy in metastatic breast cancer: many choices and future directions | SpringerLink
How PERJETA® (pertuzumab) works for HER2+ Breast Cancer | HCP
Cancers | Free Full-Text | Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer
Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity | Bentham Science
Cancers | Free Full-Text | The Changing Paradigm for the Treatment of HER2-Positive Breast Cancer | HTML
How PERJETA® (pertuzumab) works for HER2+ Breast Cancer | HCP
Pertuzumab in HER2-positive early breast cancer: current use and perspectives | Future Oncology
Pertuzumab in human epidermal growth-factor receptor 2-positive breast | IJWH
Targeted therapeutic options and future perspectives for HER2-positive breast cancer | Signal Transduction and Targeted Therapy
